Perioperative Outcome of Congenital Heart Disease Surgery in Childhood

NCT ID: NCT04093011

Last Updated: 2019-09-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

6500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-01-01

Study Completion Date

2019-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Congenital heart disease is the most common congenital malformation in the world with high morbidity and mortality. However, there is no data to assess the perioperative outcome of congenital heart disease surgery among Chinese cross-regional population. This study aims to investigate the perioperative outcome of congenital heart disease surgery in childhood from a chinese cross-regional cohort.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Congenital Heart Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Congenital Heart Disease Surgery

Patients with congenital heart disease will undergo congenital heart disease surgery.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subject was aged 1 week-18 years
* Subjects underwent congenital heart disease surgery;
* Available data to investigate perioperative outcome.

Exclusion Criteria

* Cardiac reoperation;
* Emergency surgery;
* Interventional procedure within prior 30 days prior to surgery;
* Missing outcome data.
Minimum Eligible Age

1 Week

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Nanjing Medical University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Hong Liu

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Hong Liu, MD

Role: STUDY_DIRECTOR

Peking Union Medical College

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

TEDA International Cardiovascular Hospital

Tianjin, Tianjin Municipality, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Hong Liu, MD

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Hong Liu, MD

Role: primary

188012181613

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TedaICH-Thousands of plans

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Nesiritide Use Following Cardiac Surgery in Infants
NCT00281671 TERMINATED PHASE1/PHASE2